Skip to content

This Site is Intended for Healthcare Professionals Only

Search AI Powered

Latest Stories

NPA ‘Kickstarters’ begin work

The first candidate to land a work placement in a community pharmacy as part of a government scheme called Kickstart started their shift on Monday (Feb 8).

Under the scheme, the Department of Work and Pensions (DWP) pays wages and employment costs for a six-month job placement, for 16 to 24 year olds on Universal Credit who are at risk of long-term unemployment.


The NPA’s partnership with the recruitment company Reed has enabled independent community pharmacies to take part in and make the most of the government initiative.

Balvinder Singh Nijjar, director of Faith Pharmacy in Manchester said: “We applied for the scheme to give somebody a chance so they could see what pharmacy was all about.

"We have a senior member of staff helping her get familiar with the pharmacy. She can observe other staff and how they give advice over the counter and operate the till.

"If she can achieve the Medicine Counter Assistant certificate from the NPA, confidence in a workplace and some knowledge of dispensing it will put her onto a good start to carry on further.”

Nicole Wilson, the Kickstarter said: “I like learning new skills as well as being able to give back (to health services and the community). This is an opportunity for me to learn something new and when I saw this I knew it was something I could get involved with.”

Nicole says she hopes the experience can develop her for a career in a healthcare setting.

“I like the idea of progressing and picking up new skills. I like being part of something that’s constantly evolving rather than staying static. I'm looking forward to doing the NPA course too.”

The 24-year-old spent her first day shadowing the team, making sales, collecting repeat prescriptions and learning about prescription exemptions to support customers with the process.

The first phase of Kickstart applications via the NPA and Reed during November 2020 attracted over 700 placements for community pharmacies which have been approved by DWP.

The second phase, which ran in December, attracted over 600 applications from NPA members, and are currently awaiting approval from DWP. The NPA has recently opened up a third phase.

More For You

RPS group aims to tackle barriers holding back black pharmacy students

Work is underway to improve inclusivity in teaching

Pic credit: iStock

RPS group aims to tackle barriers holding back black pharmacy students

A cross-sector group aimed at tackling barriers that block the progression of black students and trainee pharmacists held its first meeting this week.

The Royal Pharmaceutical Society (RPS) has created the Differential Attainment Oversight Group to address issues that black or black British African student pharmacists and foundation trainees face such as limited access to work experience, financial support and visible role models in education and training.

Keep ReadingShow less
Older adult organizing medicine bottles in a cool, dry storage area during warm weather.

People are being advised to keep medicine below 25° C

Pic credit: iStock

Pharmacies advise patients on storing medicines safely during heatwave

Patients are being given important advice and guidance on the impact heat can have on their medicine and where to keep different medicines as the UK goes through a heatwave.

People are being advised to keep medicine below 25° C if they are able to, unless storage instructions state it needs to be kept at an alternative temperature, such as drugs that need to be refrigerated.

Keep ReadingShow less
Astrazeneca Office Building  Outlook

British Medical Journal has found data discrepancy during the crucial clinical trials of AstraZeneca's heart drug ticagrelor.

iStock

Top medics question trials of AstraZeneca's anti-clotting pill

The effectiveness of anti-clotting pill ticagrelor is now under a cloud, with some experts claiming that AstraZeneca misreported data when the trials were conducted more than a decade ago.

Sold as Brilinta, the pill was approved for use on the NHS in 2011 after trials claimed it could prevent one in five deaths after a heart attack, and the generic versions of the drug are scheduled for this year.

Keep ReadingShow less
Boots pension dispute

The Pensions Ombudsman has begun an investigation into the decision by the Trustees of Boots Pension Scheme to remove members' option to retire on an unreduced pension at age 60.

iStock

Pensions Ombudsman probing Boots pension dispute

The Pensions Ombudsman has begun an investigation into the decision by the Trustees of Boots Pension Scheme to remove members' option to retire on an unreduced pension at age 60.

According to the Pharmacists' Defence Association (PDA), the ombudsman has decided to take a ‘lead case’ approach, as several members have been affected by the issue.

Keep ReadingShow less
23andMe

More than 150,000 UK residents had their personal information taken by hackers during a data breach in 2023.

iStock

UK watchdog fines 23andMe £2.31m for data breach

Genetic testing firm 23andMe has been fined £2.31 million by a UK watchdog over a 2023 data breach, when the personal information of seven million people across the world was stolen.

The Information Commissioner's Office (ICO) said the California-based company, which later filed for bankruptcy, failed to put adequate measures in place to secure sensitive user data.

Keep ReadingShow less